| Literature DB >> 34674968 |
Charles Darko-Takyi1, Andrew Owusu-Ansah2, Frank Boampong3, Enyam Komla Morny2, Francisca Hammond2, Stephen Ocansey2.
Abstract
PURPOSE: This study aimed to investigate the correlation between convergence insufficiency symptom survey (CISS) score and the signs of convergence insufficiency (CI) and to evaluate the sensitivity and specificity of the CISS to predict CI and ametropia among young adult university students.Entities:
Keywords: Convergence insufficiency; Convergence insufficiency symptoms survey score; Correlations; Sensitivity; Specificity; University students
Mesh:
Year: 2021 PMID: 34674968 PMCID: PMC9237593 DOI: 10.1016/j.optom.2021.05.001
Source DB: PubMed Journal: J Optom ISSN: 1989-1342
Descriptive measures of parameters investigated.
| Parameter | 25th Percentile | Median | IQR | 75th Percentile | 90th Percentile | Mean ± SD | 95% CI | Shapiro-Wilk p-values |
|---|---|---|---|---|---|---|---|---|
| CISS score | 8 | 13 | 14 | 22 | 28.9 | 15.21±10.02 | 14.07 – 16.35 | 0.0001 |
| CISS males | 7 | 15 | 15 | 22 | 27.2 | 15.26±9.49 | 13.81 – 16.71 | 0.001 |
| CISS females | 8 | 12 | 14 | 22 | 31 | 15.16±10.69 | 13.32 – 16.99 | 0.0001 |
| Age males | 20 | 22 | 4 | 24 | 25 | 22.13±2.22 | 21.79 – 22.08 | 0.0001 |
| Age females | 19.5 | 21 | 3 | 22 | 24 | 20.90±1.92 | 20.57 – 21.23 | 0.0001 |
| NPC break | 4 | 6 | 6 | 10 | 15 | 7.64±4.476 | 7.13 – 8.15 | 0.0001 |
| NPC rec | 6 | 8 | 6 | 12 | 17 | 9.25±4.787 | 8.71 – 9.80 | 0.0001 |
| Exo N ∆ | 2 | 3 | 1 | 4 | 4.8 | 3.09±0.944 | 2.46 – 3.73 | 0.095 |
| PFV blur N | 18 | 20 | 3 | 21 | 24 | 19.91±2.84 | 18 – 21.82 | 0.535 |
| PFV break N | 21 | 23 | 4 | 25 | 27.8 | 23.09±2.95 | 21.11- 25.07 | 0.987 |
| PFV rec N | 16 | 18 | 3 | 19 | 21.6 | 17.73±2.28 | 16.19 – 19.26 | 0.990 |
| AC/A ratio | 3 | 3 | 1 | 4 | 5.6 | 3.45±1.04 | 2.79 – 4.15 | 0.011 |
| Exo D ∆ | 2 | 2 | 1 | 3 | 3 | 2.44±0.796 | 2.21 – 2.67 | 0.0001 |
| Eso D ∆ | 1 | 2 | 1 | 2 | 2.8 | 1.73±0.647 | 1.29 – 2.16 | 0.008 |
| Eso N ∆ | 2 | 3.5 | 4 | 6 | 6.9 | 3.80±1.989 | 2.38 – 5.22 | 0.530 |
| Myopia | 0.50 | 0.75 | 0.5 | 1.00 | 1.75 | 0.89±0.48 | 0.72 – 1.06 | 0.0001 |
| Hyperopia | 0.50 | 0.50 | 0.25 | 0.75 | 1.00 | 0.67±0.31 | 0.59 – 0.74 | 0.0001 |
| Astigmatism | 0.50 | 0.63 | 0.25 | 0.75 | 1.25 | 0.75±.416 | 0.64 – 0.84 | 0.0001 |
| CI (CISS) | 23 | 33 | 16 | 38.5 | 43 | 30.24±10.55 | 26.27 – 34.21 | 0.074 |
| No CI (CISS) | 7 | 12 | 12 | 19 | 25 | 13.61±8.55 | 12.58 - 14.63 | 0.0001 |
| CISS Ame | 9 | 16 | 15 | 24 | 35 | 17.00±9.49 | 15.56 – 18.44 | 0.0001 |
| CISS Emm | 5 | 11 | 13 | 18 | 30 | 12.13±9.49 | 10.54 – 14.06 | 0.0001 |
IQR – interquartile range, CISS- convergence insufficiency symptom survey, Exo- exophoria, N- near, PFV- Positive fusional vergence, rec – recovery, Eso- esophoria, D- distance, CI- convergence insufficiency, Ame- Ametropia, Emm- Emmetropia.
Frequencies of various conditions investigated.
| Condition | Frequency | Percentage (%) |
|---|---|---|
| Emmetropia | 114 | 38 |
| Myopia | 34 | 11.3 |
| Hyperopia | 62 | 20.7 |
| Astigmatism | 90 | 30 |
| 300 | 100% | |
| Symptomatic participants | ||
| (CISS score ≥21) | 84 | 28 |
| Asymptomatic participants | ||
| (CISS score ˂ 21) | 216 | 72 |
| 300 | 100% | |
| Convergence insufficiency | 29 | 9.7 |
| No Convergence insufficiency | 271 | 90.3 |
| 300 | 100% | |
| 0 | 183 | 61 |
| 1 | 53 | 17.7 |
| 2 | 35 | 11.7 |
| 3 | 16 | 5.33 |
| 4 | 13 | 4.33 |
| 300 | 100% | |
Descriptive parameters of participants with convergence insufficiency.
| Parameter | 25th Percentile | Median | IQR | 75th Percentile | 90th Percentile | Mean ± SD | 95% Confidence Interval | Shapiro-Wilk p-values |
|---|---|---|---|---|---|---|---|---|
| NPC break | 12 | 15 | 6 | 18 | 20 | 15.03±4.09 | 13.48 – 16.59 | 0.404 |
| NPC rec | 13.50 | 10 | 7 | 20.5 | 22 | 17.14±4.25 | 15.52 - 18.75 | 0.566 |
| Exo N ∆ | 7 | 8 | 3 | 10 | 12 | 8.83±2.07 | 8.04 - 9.62 | 0.003 |
| PFV blur N | 13 | 14 | 3 | 15.5 | 16 | 13.93±2.65 | 12.92- 14.94 | 0.0001 |
| PFV break N | 16.5 | 18.0 | 4 | 20.0 | 22.0 | 17.93±3.63 | 16.55-19.31 | 0.002 |
| PFV rec N | 11 | 14 | 5 | 16 | 17 | 13.28±3.12 | 12.09-14.46 | 0.027 |
| AC/A ratio | 2 | 2 | 1 | 3 | 3 | 2.48±0.34 | 2.24- 2.72 | 0.0001 |
| Exo D ∆ | 2 | 2 | 2 | 3.5 | - | 2.78±1.39 | 1.71- 3.85 | 0.0001 |
| Difference in parameters between symptomatic and asymptomatic convergence insufficiency participants | ||||||||
| Mean ± SD | t-value | P -values | ||||||
| NPC break | 15.62±3.78 | 10.00±2.00 | 2.442 | 0.021 | 0.90 – 10.33 | |||
| NPC recovery | 17.81±3.90 | 11.33±2.52 | 2.784 | 0.010 | 1.70 – 11.25 | |||
| Mean ranks | U | Z | P - values | |||||
| Exo N ∆ | 15.6 | 9.83 | 23.5 | -1.133 | 0.257 | |||
| PFV blur N | 15.23 | 13.00 | 33.0 | -0.439 | 0.663 | |||
| PFV break N | 15.56 | 10.17 | 24.5 | -1.061 | 0.289 | |||
| PFV rec N | 15.31 | 12.33 | 31.0 | -0.577 | 0.564 | |||
| AC/A ratio | 14.64 | 18.00 | 30.0 | -0.740 | 0.459 | |||
| Exo D ∆ | 4.75 | 7.00 | 2 | -0.920 | 0.357 | |||
NPC – near point of convergence, IQR – interquartile range, Exo- exophoria, N- near, PFV- Positive fusional vergence, rec – recovery, D- distance, CI – convergence insufficiency
Correlation between CISS score and signs of CI.
| Sign of CI | CISS score | |
|---|---|---|
| Spearman Rho (rs) | ||
| NPC break | 0.622 | 0.0001 |
| NPC recovery | 0.620 | 0.0001 |
| Near exophoria | 0.434 | 0.0001 |
| PFV(blur at near) | - 0.359 | 0.0001 |
| PFV (break at near) | - 0.306 | 0.0001 |
| PFV (recovery at near) | - 0.326 | 0.0001 |
| Gradient AC/A ratio | - 0.290 | 0.0001 |
Fig. 1Positive correlation between CISS score and NPC break.
Fig. 2Positive correlation between CISS score and exophoria at near.
Fig. 3Negative correlation between CISS score and AC/A ratio.
Fig. 4Scatterplot matrix showing negative correlation between CISS score and PFV amplitudes.
Fig. 5Positive correlation between CISS score and number of signs of CI.
Fig. 6ROC Curve indicating good sensitivity and specificity of CISS to predict CI. AOC is equal to 0.882.
Fig. 7ROC Curve indicating poor sensitivity and specificity of CISS to predict ametropia. AOU is equal to 0.642.